Accutane Lawyers and Attorneys - Free Accutane Case Evaluation

Free Accutane Case Evaluation

In 1998, the Food and Drug Administration advised doctors who prescribe Accutane to watch their patients for signs of depression. Afterward, the Hoffman-LaRoche, the maker of Accutane, notified doctors that the drug ``may cause depression, psychosis, and, rarely, suicidal ideation, suicide attempts and suicide.'' If you have been injured by Accutane, Click Here for a Free Accutane Case Evaluation.

However, the knowledge of the potential danger associated with Accutane did not become widely known until a Congressman's son committed suicide. Rep. Bart Stupak says his 17-year-old son's suicide earlier this year may be linked to the popular acne medicine. Bart Stupak Jr., known as "B.J.," shot himself in the head with his father's gun in the early hours of May 14. Stupak was popular in school, a football player, and killed himself after a prom-night party.

In assessing how many potential suicide cases could be linked to Accutane, Rep. Stupak stated, "We are up over 100 reports, that's just what is coming in to us, so I believe there are probably over a thousand cases," Stupak said. "The average time is 88 days from when you start taking it, and the effect is very sudden.... You are doing strange things at 3 a.m. and you are dead at 7 a.m."

The FDA has received reports of 66 suicides and 1,373 cases of psychiatric problems among Accutane users as of early December, 2000 according to a report in USA Today. Accutane's package warning first stated potential relationship between Accutane and depression in 1986. Although French officials required that Hoff-LaRoche add the risk of suicide to the package insert of the European version of Accutane in March 1997, the FDA did not require such a change in the USA until 1999.

Click Here for a Free Accutane Case Evaluation.

HOME ABOUT US DISCLAIMER FREE EVALUATION CONTACT US